Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.027 | 0.6 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |